The Survival Impact of Fluoropyrimidine Metronomic Maintenance Therapy Following Adjuvant Oxaliplatin-based Chemotherapy in Patients with Stage III Colorectal Cancer after Radical Resection: Functional Roles of EGFR as a Potential Predictor
How to cite: Huang, C.-W.; Ma, C.-J.; Chen, Y.-T.; Tsai, H.-L.; Yeh, Y.-S.; Su, W.-C.; Chang, T.-K.; Hsu, W.-H.; Yu, F.-J.; Wang, J.-Y. The Survival Impact of Fluoropyrimidine Metronomic Maintenance Therapy Following Adjuvant Oxaliplatin-based Chemotherapy in Patients with Stage III Colorectal Cancer after Radical Resection: Functional Roles of EGFR as a Potential Predictor. Preprints 2019, 2019090036. https://doi.org/10.20944/preprints201909.0036.v1 Huang, C.-W.; Ma, C.-J.; Chen, Y.-T.; Tsai, H.-L.; Yeh, Y.-S.; Su, W.-C.; Chang, T.-K.; Hsu, W.-H.; Yu, F.-J.; Wang, J.-Y. The Survival Impact of Fluoropyrimidine Metronomic Maintenance Therapy Following Adjuvant Oxaliplatin-based Chemotherapy in Patients with Stage III Colorectal Cancer after Radical Resection: Functional Roles of EGFR as a Potential Predictor. Preprints 2019, 2019090036. https://doi.org/10.20944/preprints201909.0036.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)